AbbVie (ABBV)

R&D Expense Growth

-5.18%

Quarterly · Period ending:

ABBV logo

ABBV R&D Expense Growth

Latest reported-5.18%
ABBV Quarterly R&D Growth (QoQ) (0.00% → -5.18%)
High-resolution chart · PNG

ABBV r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

AbbVie R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-5.178%
-4.1489%
11.2117%
8.8221%
3.0963%
-69.4863%
218.0282%
9.3429%
0.4642%
-12.2227%
28.2066%
-0.577%
-24.3892%
12.7398%
22.9141%
-11.9276%
14.3727%
-26.4337%
8.192%
8.6361%
2.5378%
-15.4338%
25.0714%
-28.0903%
76.5772%
-17.9655%
-26.4333%
65.3401%
-4.2936%
-78.7491%
413.6054%
0.0756%
0.6855%
-23.3956%
39.5765%
-1.2862%
8.9317%
-7.1545%
3.7099%
-0.67%
24.8954%
-11.0698%
-24.189%
41.2351%
7.0362%
3.4179%
-19.0179%
31.7647%
10.1036%
-8.747%
-9.4218%
19.8973%
22.8707%
-34.5866%
19.2154%
8.1117%
-5.0505%
2.1765%
16.4695%
12.8463%
0.4534%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.